# Dopamine Treatment in Children With Cerebral Palsy With Dystonia- A Double Blind Controlled Study

> **NCT01361373** · PHASE4 · UNKNOWN · sponsor: **Shaare Zedek Medical Center** · enrollment: 50 (estimated)

## Conditions studied

- Dystonic Cerebral Palsy

## Interventions

- **DRUG:** L- DOPA
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01361373
- **Lead sponsor:** Shaare Zedek Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-05
- **Primary completion:** 2012-05
- **Final completion:** 2012-08
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2011-05-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01361373

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01361373, "Dopamine Treatment in Children With Cerebral Palsy With Dystonia- A Double Blind Controlled Study". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT01361373. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*